In vitro activities of ceftobiprole, dalbavancin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus blood isolates: stratified analysis by vancomycin MIC

详细信息	查看全文 | 推荐本文 |

• 作者：Yong Pil Chong^a ; ^c ; Su-Jin Park^a ; ^c ; Hee Sueng Kim^a ; ^c ; Eun Sil Kim^a ; ^c ; Mi-Na Kim^b ; Sung-Han Kim^a ; ^c ; Sang-Oh Lee^a ; ^c ; Sang-Ho Choi^a ; ^c ; Jin-Yong Jeong^a ; ^c ; ^d ; Jun Hee Woo^a ; ^c ; Yang Soo Kim^a ; ^c ; ^{yskim@amc.seoul.kr}
• 关键词：MRSA ; Bacteremia ; Antibiotics ; Susceptibility
• 刊名：Diagnostic Microbiology and Infectious Disease
• 出版年：2012
• 期刊代码：79_07328893
• 类别：med
• 出版时间：July, 2012
• 卷：73
• 期：3
• 页码：264-266
• 文件大小：151 K

摘要

The in vitro activities of newer agents against 569 methicillin-resistant Staphylococcus aureus (MRSA) blood isolates stratified by vancomycin MIC values (鈮? versus >1 渭g/mL) were evaluated using broth microdilution methods. All agents had good in vitro activities against MRSA regardless of vancomycin MIC values. Some significant correlations between vancomycin and newer agents' MIC values were observed.